Alex Asbill
Senior Associate
Get their honest, personalized take on your startup.
Sign in to pitch Alex →At a glance
- Full Name
- Alex Asbill
- Title
- Principal (previously Vice President; formerly Senior Associate)
- Firm
- Gauge Capital
- Firm Type
- Middle-market private equity (control/growth buyouts) — *not an angel investor, despite the stub data*
- Investment Stage
- Later-stage / buyout & recapitalization (control equity in established companies), *not seed*
- Check Size
- ~$20M–$100M equity per platform investment (Gauge fund-level)
- Target Company Profile
- Established lower-middle-market and middle-market companies with proven cash flow; platform buyouds and add-on acquisitions
- Sector Focus
- Food & Consumer, and Healthcare (co-leads branded durables, PPM, post-acute, DME, and payor services); firm-wide also Business Services, Technology, and Industrial
- Geographic Focus
- North America (U.S.)
- Location
- Dallas–Fort Worth Metroplex, Texas (Gauge is based in Southlake, TX)
Background
Alex Asbill is a Principal at Gauge Capital, a Dallas-area middle-market private equity firm. He joined the firm in 2018 as an Associate, was promoted to Senior Associate, and in September 2021 became Vice President — noted at the time as the first Gauge Associate to be promoted directly to Vice President. He has since been elevated to Principal. His work centers on the firm's Food, Consumer and Healthcare practice, where he is responsible for identifying and evaluating investment opportunities, executing transactions, and supporting portfolio company management teams.
Before joining Gauge, Asbill worked at Robert W. Baird in Chicago, where he focused on mergers and acquisitions for clients in the technology and business services sectors. He earned his BBA in finance and marketing from Baylor University.
Within healthcare, Asbill co-leads Gauge's investing efforts across branded durables, physician practice management (PPM), post-acute care, durable medical equipment (DME), and payor services. As part of that mandate he takes board roles at portfolio companies — for example, joining the Board of Directors of Reliable Medical following Gauge's January 2026 investment.
Note on the stub data: the labels "Angel Investor" and "Seed Round" appear to be inaccurate. Asbill is a private-equity investor at a control-oriented buyout firm, and Gauge writes institutional equity checks into established companies rather than seed-stage startups.
Investment Thesis & Focus
- Invests through Gauge Capital, a middle-market buyout firm that typically deploys roughly $20M–$100M of equity per platform (Gauge III closed at $800M in 2020).
- Targets established, cash-flow-positive middle-market businesses for control buyouts, recapitalizations, and buy-and-build add-on strategies — not early-stage venture.
- Personal sector emphasis: Food & Consumer and Healthcare, with deep specialization in healthcare sub-sectors (branded durables, PPM, post-acute, DME, payor services).
- Value creation approach is operationally driven — supporting management teams and pursuing add-on acquisitions to grow platforms, consistent with Gauge's stated model of partnering with experienced operators.
Notable Investments
- Reliable Medical (Jan 2026) — Nashville-based provider of Complex Rehabilitation Technology and mobility/home medical equipment (founded 1989). Gauge acquired the company from prior sponsor Seven Hills Capital in a growth recapitalization; Asbill joined the Board of Directors alongside Gauge's David Friedman and Alex Amato.
- Broader Gauge Food/Consumer and Healthcare platform work falls within his practice area, though publicly attributed board/deal roles beyond Reliable Medical are limited in disclosed sources.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.